Company: XAIR
Filing Date: 2025-06-20
Form Type: 10-K
Source: 0001641172-25-015750
Chunk: 2168

Company: Beyond Air, Inc.
Filing Date: 2025-06-20
Form: 10-K
Item: Item 8
Chunk 2168
---
 CONSOLIDATED FINANCIAL STATEMENTS

NOTE 14 VARIABLE INTEREST
ENTITIES (continued)

The following table summarizes segment financial information
by business segment for the year ended and at March 31, 2024:

 SCHEDULE
OF SEGMENT FINANCIAL INFORMATION BY BUSINESS SEGMENT

    (in thousands) 
    Beyond Air  
    Beyond Cancer  
     NeuroNos  
    Total 
  
    Cash, cash equivalents and marketable securities 
    $23,591  
    $10,877  
    $      -  
    $34,468 
  
    All other assets 
     21,747  
     746  
     -  
     22,493 
  
    Total assets 
    $45,338  
    $11,623  
    $-  
    $56,961 
  
    Total liabilities 
     (28,810) 
     (965) 
     -  
     (29,775)
  
    Net assets 
    $16,528  
    $10,658  
    $-  
    $27,186 
  
    Non-controlling interest 
    $-  
    $2,138  
    $-  
    $2,138 
  
    Capital expenditures 
    $5,502  
    $243  
    $-  
    $5,745 

    Revenues 
    $1,159  
    $-  
    $-  
    $1,159 
  
    Cost of revenues 
     (2,466) 
     -  
     -  
     (2,466)
  
    Research and development 
     (15,527) 
     (8,836) 
     -  
     (24,363)
  
    Selling, general, and administrative 
     (25,271) 
     (12,066) 
     -  
     (37,337)
  
    Loss from operations 
     (42,105) 
     (20,902) 
     -  
     (63,006)
  
    Interest and finance expense 
     (2,912) 
     -  
     -  
     (2,912)
  
    Other non-operating income/(expense)